30 results about "Prostate hypertrophy" patented technology

The invention provides a pharmaceutical composition for preventing and treating climacteric metancholia and other diseases, relating to the field of medical technology, and particularly providing a new application of a pharmaceutical composition which is called as Qi-replenishing sharp and bright decoction and is composed of ginseng or codonopsis pilosula, astragalus membranaceus, cimicifugae foetidae, root of kudzuvine, simpleleaf shrub chastetree fruit, radix paeoniae alba, cortex phellodendri and liquorice in the preparation of a drug or food for preventing and treating climacteric metancholia, senile chronic vaginitis, senile chronic urethritis or cystitis, and senile chronic prostate hypertrophy as a main raw material. In addition, the invention further relates to an application of a new pharmaceutical composition which is obtained according to the modification of prescription of the Qi-replenishing sharp and bright decoction or the prescription of the Qi-replenishing sharp and bright decoction in the preparation of a drug or food for preventing and treating the diseases above as a main raw material. The pharmaceutical composition for preventing and treating climacteric metancholia and other diseases provided by the invention has the advantages that the raw materials of the pharmaceutical composition can be mixed after crushing to powder independently or crushed to powder after mixing, the edible preparation can be prepared directly, the raw materials can be mixed after extracting independently or extracted after mixing, and the pharmaceutical composition is prepared into all the normally used pharmaceutical dosage forms such as pills, powders, capsules, tablets, medicinal granules, oral liquids and the like together with pharmaceutically acceptable accessories.

The present invention discloses a group of plant preparations made of cassia twig (or cinnamon) for inhibiting prostate hypertrophy and releasing urinary dysfunction and a preparation method thereof. The group of plant preparations can be used as medicine, nutritional agent and food for inhibiting prostate hypertrophy and releasing urinary dysfunction.

The invention discloses a Chinese herbal compound for treating benign prostatic hyperplasia and the preparation method. The invention is characterized in that the compound is prepared with raw materials of prunus African, pollen, dandelion and flos chrysanthemi indici (wild chrysanthemum flower) which are extracted and refined in a proper process. The invention also discloses preparation methods of various preparations which are produced with the compound and acceptable in pharmacy and applications of the preparations in the prevention field of the benign prostatic hyperplasia.

Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.

The invention relates to a pharmaceutical preparation for hyperplasia of prostate. The pharmaceutical preparation is prepared from the following raw materials: 2.5kg of finasteride, 9.2kg of starch, 9.2kg of pregelatinized starch, 13.5kg of lactose, 11.6kg of microcrystalline cellulose, 2.5kg of sodium carboxymethyl starch, 25kg of 2% hydroxypropyl methylcellulose pulp and 0.15kg of magnesium stearate; and the raw materials are granulated by a conventional method to prepare 500,000 tablets. The product provided by the invention realizes an obvious and stable treatment effect on hyperplasia of prostate and has a broad application prospect.

The invention discloses a traditional Chinese medicinal material compound extract for reducing benign prostatic hyperplasia symptoms. The extract is prepared by taking saxifraga stolonifera and salvia miltiorrhiza as raw materials. According to the extract disclosed by the invention, the prostate gland weight of the benign prostatic hyperplasia symptoms can be obviously reduced, and the price is low.

The invention provides a drug composition for treating prostatic hyperplasia. The drug composition is composed of following components: a pygeum topengii bark extract, a urtica dioica root extract, beta-sitosterol, lycopene, zinc citrate, selenium and vitamin E. According to the drug composition for treating prostatic hyperplasia, by combining traditional Chinese medical herbs with western medicine, a compound is formed; and the drug composition rapidly comes into effect, can rapidly relieve prostatic hyperplasis symptoms and rapidly alleviate pain of patients, can achieve radical treatment and is short in treatment course, and prostatic hyperplasia does not easily relapse.

The present invention discloses one kind of Chinese medicine composition prepared with red sage, astragalus root, knotgrass, plantain seed, walnut kernel and other four kinds of Chinese medicinal materials. The Chinese medicine composition may be tablet, capsule, bolus, granule or oral liquid. The Chinese medicine composition has the functions of promoting urination, relieving stranguria, refreshing, promoting intelligence growth, invigorating kidney, improving eyesight and clearing away heat and toxic material, and may be used in preventing and treating senile dementia and prostate hypertrophy.

Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with hair loss or prostate cancer/prostate hypertrophy are described herein. These select phytoestrogen formulations are preferably composed only of two or more plant-derived estrogenic molecules and/or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in non-reproductive tissues including brain.

The invention belongs to the technical field of traditional Chinese medicines, and in particular discloses a Chinese medicine composition for treating hyperplasia of prostate and a preparation method of the Chinese medicine composition. The Chinese medicine composition is prepared from the following Chinese medicinal herbs in parts by weight: 5-10 parts of fried rhizoma atractylodis, 5-10 parts of amur cork tree bark, 5-15 parts of cortex mori radicis, 10-15 parts of plantain seed, 3-10 parts of parched pangolin, 3-10 parts of common burreed rhizome, 5-10 parts of fired semen vaccariae, 5-15 parts of lumbricus, 3-9 parts of safflower, 5-15 parts of Chinese angelica, 6-15 parts of medicinal cyathula root, 1.5-3 parts of amber, 10-60 parts of astragalus, 5-10 parts of ginseng, 3-15 parts of radix aconiti lateralis preparata and 5-10 parts of pulp of dogwood fruit. The Chinese medicine composition has the effects of clearing heat, promoting dieresis, nourishing qi, warming kidney, resolving hard lump, and dispersing blood stasis, and has quick treatment effect on the hyperplasia of prostate with definite treatment effect.

The invention relates to a traditional Chinese medicine preparation for treating hyperplasia of prostate and a preparation method thereof. The traditional Chinese medicine preparation is prepared from the following crude drugs in parts by weight: 8-15 parts of ground beetle, 7-14 parts of herba lysimachiae, 5-11 parts of centella asiatica, 3-11 parts of radix dipsaci, 8-17 parts of portulaca oleraceal, 4-10 parts of astragalus membranaceus, 3-12 parts of leeches, 4-14 parts of radix rehmanniae preparata, 6-12 parts of dandelion, 5-10 parts of dragon bone, 2-9 parts of andrographis paniculata, 2-7 parts of polygala tenuifolia and 8-13 parts of eucommia ulmoides. According to the traditional Chinese medicine preparation for treating hyperplasia of prostate and the preparation method thereof, provided by the invention, the treating effect on hyperplasia of prostate is obvious, and at the same time the efficacies of strengthening tendons and bones, delaying senescence and improving body immunity are achieved; besides, the traditional Chinese medicine preparation has the characteristics of being unique in formula and reasonable in compatibility, is further easy in operation and preparation, free of the toxic and side effect, and particularly suitable for being taken by patients, especially senile patients.